What are glucametacin drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

glucametacin drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

glucametacin

0 marketed 1 in Phase 2

This page covers all glucametacin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 2 pipeline (1)

Glucamethacin · Pain
Glucametacin is thought to work by inhibiting the production of prostaglandins, which are hormone-like substances that contribute to inflammation and pain.

Patent intelligence

glucametacin patent landscape — aggregated cliff calendar, attackable patents, originator estates